Amdocs earnings matched, revenue was in line with estimates

Investing.com – Amdocs (NASDAQ: ) reported fourth quarter EPS of $1.42, in line with the analyst estimate of $1.42. Revenue for the quarter came in at $1.24B versus the consensus estimate of $1.24B.

Guidance

Amdocs sees Q1 2024 EPS of $1.53-$1.59 versus the analyst consensus of $1.60.

Amdocs sees Q1 2024 revenue of $1.23B-$1.27B versus the analyst consensus of $1.27B.

Amdocs’s stock price closed at $83.69. It is down -5.05% in the last 3 months and up 2.42% in the last 12 months.

Amdocs saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Amdocs’s stock price’s past reactions to earnings here.

According to InvestingPro, Amdocs’s Financial Health score is “good performance”.

Check out Amdocs’s , and Amdocs’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar